Short Reads

Premium

Sequenom faces class action lawsuits on behalf of shareholders after the firm announced that it will delay the launch of a test for Down syndrome on discovering that employees had mishandled R&D test data and results. Sequenom CEO Harry Stylli said four employees had been suspended and that the company put a new team in place to oversee studies of its prenatal diagnostics.

John Rossi, co-founder of Dicerna Pharmaceuticals, won the 2008 Cozzarelli Prize from the Proceedings of the National Academy of Sciences' Editorial Board for work using microRNAs for gene silencing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

CNBC reports that Amazon invested in the startup Grail as it sees it as opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.